MedBright AI Investments and The Ken Sperling Lecture Series Support Medical Economics Lectures at Yale University Medical School
MedBright AI Investments and The Ken Sperling Lecture Series Support Medical Economics Lectures at Yale University Medical School
MedBright AI Investments and The Ken Sperling Lecture Series Support Medical Economics Lectures at Yale University Medical School
MedBright AI Investments 和 Ken Sperling 系列講座支持耶魯大學醫學院的醫學經濟學講座
VANCOUVER, BC / ACCESSWIRE / November 22, 2023 / MedBright AI Investments Inc. (the "Company" or "MedBright") (CSE:MBAI)(OTCQB:MBAIF)(FSE:1V7) is pleased to announce it, along with The Ken Sperling Lecture Series, will be supporting and participating in medical economics lectures at Yale University School of Medicine.
不列顛哥倫比亞省溫哥華/ACCESSWIRE/2023年11月22日/MedBright AI Investments Inc.(以下簡稱 “公司” 或 “MedBright”)(CSE: MBAI)(OTCQB: MBAIF)(FSE: 1V7)欣然宣佈,它將與肯·斯珀林系列講座一起支持和參與耶魯大學醫學院的醫學經濟學講座。
The Ken Sperling Lecture Series was founded in honor of Ken Sperling, who advised federal lawmakers and the Obama administration on the development and implementation of the 2010 health care reform law and was a pioneer in health insurance exchanges in the United States. His legacy continues with a twice annual lecture series and symposia for the house staff at Yale Medical School focused on a range of topics associated with the economics of healthcare in the US. Amongst other topics, the series will address the impact AI is having on healthcare services in the US.
肯·斯珀林系列講座是爲了紀念肯·斯珀林而創立的。肯·斯珀林曾就2010年醫療改革法的制定和實施向聯邦議員和奧巴馬政府提供建議,並且是美國健康保險交易所的先驅。他的遺產延續了耶魯醫學院每年兩次的系列講座和研討會,重點討論與美國醫療經濟學有關的一系列話題。除其他主題外,該系列還將探討人工智能對美國醫療保健服務的影響。
"I am excited to participate in working to support the house staff at Yale New Haven Hospital and Yale University Medical School," said Michael Dalsin, Chair of the MedBright AI Investment. "We share the same commitment to create lectures and symposia on the topic of Healthcare Microeconomics, especially as we see a wide array of applications using artificial intelligence in the business of healthcare."
他說:“我很高興能參與支持耶魯紐黑文醫院和耶魯大學醫學院院內工作人員的工作。” 邁克爾·達爾辛,MedBright AI Investment 主席。“我們同樣致力於舉辦以醫療微觀經濟學爲主題的講座和研討會,尤其是在我們看到人工智能在醫療保健業務中有廣泛應用的情況下。”
About Yale School of Medicine
Yale School of Medicine educates and nurtures creative leaders in medicine and science, promoting curiosity and critical inquiry in an inclusive environment enriched by diversity.
耶魯醫學院簡介
耶魯醫學院教育和培養醫學和科學領域的創造性領袖,在充滿多樣性的包容性環境中促進好奇心和批判性探究精神。
About MedBright AI Investments Inc.
MedBright AI is a capital allocator focused on investing in healthcare technology companies. The team at Medbright prides themselves on unparalleled access to opportunities, as well as structuring unique and advantageous investments. Medbright's mission is to construct a portfolio of synergistic investments to generate superior returns for shareholders. MedBright will focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.
關於 MedBright AI 投資公司
MedBright AI是一家專注於投資醫療科技公司的資本分配機構。Medbright的團隊以獲得無與倫比的機會以及構建獨特而有利的投資而自豪。Medbright的使命是建立協同投資組合,爲股東創造豐厚的回報。MedBright將專注於具有強大回報潛力的重大短期和中期高質量機會,同時保持對治理的承諾。
MedBright AI Investments Inc.
Alnoor Nathoo, Chief Executive Officer
(587)-899-6967
Email: investors@medbright.ai
MedBright AI 投資公司
Alnoor Nathoo,首席執行官
(587) -899-6967
電子郵件: investors@medbright.ai
Cautionary Statement Regarding "Forward-Looking" Information
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including without limitation, the Company's plans to generate returns for its shareholders through its portfolio of investments, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should" or "would" or occur.
關於 “前瞻性” 信息的警示聲明
本新聞稿包含某些陳述和信息,這些陳述和信息可能構成適用的加拿大證券法所指的前瞻性信息。除歷史事實陳述外,本新聞稿中的所有陳述,包括有關未來業績估計、計劃、目標、時機、假設或預期的陳述,包括但不限於公司通過投資組合爲股東創造回報的計劃,均爲前瞻性陳述,包含前瞻性信息。通常,前瞻性陳述和信息可以通過使用前瞻性術語來識別,例如 “打算” 或 “預期”,或者某些行動、事件或結果 “可能”、“應該” 或 “將會” 發生的詞語和短語或陳述的變體。
Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including that the Company will be able to generate returns for its shareholders. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important risks that may cause actual results to vary, include, without limitation, the risk that the Company's portfolio of investments will not generate returns for shareholders.
前瞻性陳述基於公司做出的某些重大假設和分析,以及截至本新聞稿發佈之日管理層的意見和估計,包括公司將能夠爲股東創造回報的意見和估計。這些前瞻性陳述受已知和未知的風險、不確定性和其他因素的影響,這些因素可能導致公司的實際業績、活動水平、業績或成就與此類前瞻性陳述或前瞻性信息所表達或暗示的結果存在重大差異。可能導致實際業績變化的重要風險包括但不限於公司的投資組合無法爲股東帶來回報的風險。
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.
儘管公司管理層試圖確定可能導致實際業績與前瞻性陳述或前瞻性信息中包含的結果存在重大差異的重要因素,但可能還有其他因素導致業績與預期、估計或預期的結果不符。無法保證此類陳述會被證明是準確的,因爲實際結果和未來事件可能與此類聲明中的預期存在重大差異。因此,讀者不應過分依賴前瞻性陳述和前瞻性信息。提醒讀者,依賴此類信息可能不適合用於其他目的。除非符合適用的證券法,否則公司不承諾更新此處以引用方式納入的任何前瞻性陳述、前瞻性信息或財務展望。
SOURCE: MedBright AI Investments Inc.
來源:MedBright AI 投資公司